Authors:
CORTES JE
KANTARJIAN H
OBRIEN S
ROBERTSON LE
KOLLER C
HIRSHGINSBERG C
STASS S
KEATING M
ESTEY E
Citation: Je. Cortes et al., ALL-TRANS-RETINOIC ACID FOLLOWED BY CHEMOTHERAPY FOR SALVAGE OF REFRACTORY OR RELAPSED ACUTE PROMYELOCYTIC LEUKEMIA, Cancer, 73(12), 1994, pp. 2946-2952
Citation: Hs. Juneja et al., ADHERENCE OF PURIFIED CHRONIC LYMPHOCYTIC-LEUKEMIA CELLS TO MARROW STROMAL CELLS IS MEDIATED BY BOTH BETA-1-INTEGRINS AND BETA-2-INTEGRINS, Blood, 84(10), 1994, pp. 10000454-10000454
Authors:
ROBERTSON LE
GARSON M
PUGH W
MANNING J
HUH Y
ALBITAR M
KHOURI I
LERNER S
OBRIEN S
KEATING MJ
Citation: Le. Robertson et al., THE 11-14 TRANSLOCATION IN CHRONIC LYMPHOCYTIC-LEUKEMIA IS ASSOCIATEDWITH SPLENOMEGALY ADVANCED DISEASE, AND SHORT SURVIVAL, Blood, 84(10), 1994, pp. 10000457-10000457
Authors:
ROBERTSON LE
HALL R
KEATING MJ
ESTEY E
KANTARJIAN HM
MCLAUGHLIN P
HAGEMEISTER FB
PLUNKETT W
Citation: Le. Robertson et al., HIGH-DOSE CYTOSINE-ARABINOSIDE IN CHRONIC LYMPHOCYTIC-LEUKEMIA - A CLINICAL AND PHARMACOLOGICAL ANALYSIS, Leukemia & lymphoma, 10(1-2), 1993, pp. 43-48
Authors:
PLUNKETT W
GANDHI V
HUANG P
ROBERTSON LE
YANG LY
GREGOIRE V
ESTEY E
KEATING MJ
Citation: W. Plunkett et al., FLUDARABINE - PHARMACOKINETICS, MECHANISMS OF ACTION, AND RATIONALES FOR COMBINATION THERAPIES, Seminars in oncology, 20(5), 1993, pp. 2-12
Authors:
OBRIEN S
KANTARJIAN H
BERAN M
SMITH T
KOLLER C
ESTEY E
ROBERTSON LE
LERNER S
KEATING M
Citation: S. Obrien et al., RESULTS OF FLUDARABINE AND PREDNISONE THERAPY IN 264 PATIENTS WITH CHRONIC LYMPHOCYTIC-LEUKEMIA WITH MULTIVARIATE ANALYSIS-DERIVED PROGNOSTIC MODEL FOR RESPONSE TO TREATMENT, Blood, 82(6), 1993, pp. 1695-1700
Authors:
ROBERTSON LE
OBRIEN S
KANTARJIAN H
KOLLER C
BERAN M
ANDREEFF M
LERNER S
KEATING MJ
Citation: Le. Robertson et al., FLUDARABINE PLUS DOXORUBICIN IN PREVIOUSLY TREATED CHRONIC LYMPHOCYTIC-LEUKEMIA, Blood, 82(10), 1993, pp. 10000140-10000140
Authors:
OBRIEN S
KANTARJIAN H
ESTEY E
KOLLER C
ROBERTSON LE
BERAN M
ANDREEFF M
PIERCE S
KEATING M
Citation: S. Obrien et al., 2-CHLORODEOXYADENOSINE THERAPY IN PATIENTS WITH CHRONIC LYMPHOCYTIC-LEUKEMIA REFRACTORY TO FLUDARABINE, Blood, 82(10), 1993, pp. 10000141-10000141
Authors:
OBRIEN S
KURZROCK R
DUVIC M
STASS S
ROBERTSON LE
ESTEY E
PIERCE S
KEATING M
Citation: S. Obrien et al., 2-CHLORODEOXYADENOSINE THERAPY IN PATIENTS WITH T-CELL LYMPHOPROLIFERATIVE DISORDERS, Blood, 82(10), 1993, pp. 10000141-10000141
Authors:
SEYMOUR JF
LERNER S
ROBERTSON LE
OBRIEN S
KEATING MJ
Citation: Jf. Seymour et al., SURVIVAL OF YOUNG-PATIENTS WITH CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL) FAILING FLUDARABINE (FLU) THERAPY - A BASIS FOR THE USE OF INNOVATIVE THERAPIES, Blood, 82(10), 1993, pp. 10000389-10000389
Citation: Yo. Huh et al., EXPRESSION OF LEUKOCYTE ADHESION MOLECULES IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA, Blood, 82(10), 1993, pp. 10000390-10000390
Authors:
ROBERTSON LE
HUANG P
MCDONNELL T
PLUNKETT W
Citation: Le. Robertson et al., APOPTOSIS IN CHRONIC LYMPHOCYTIC-LEUKEMIA - CLINICAL CORRELATIONS ANDIN-VIVO EVIDENCE, Blood, 82(10), 1993, pp. 10000390-10000390